Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Pooblaščeno
- Lincomycin hydrochloride
- Spectinomycin sulfate
Identifikacija zdravila
Ime zdravila:
Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Lincospectin Pulver
Ciljne živalske vrste:
Pot uporabe:
-
Peroralna uporaba
Podatki o zdravilu
Farmacevtska oblika:
-
Prašek za dajanje v vodo za pitje
Withdrawal period by route of administration:
-
Peroralna uporaba
- Poultry
-
Meat and offal5day5 days; Animals must not be slaughtered for human consumption during treatment.
-
Eggsno withdrawal periodNot authorised for use in birds producing eggs for human consumption, including replacement chicks which are intended to produce eggs for human consumption
-
- Pig
-
Meat and offalno withdrawal period0 days; Animals must not be slaughtered for human consumption during treatment.
-
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
- QJ01FF52
Pravni status za dobavo / izdajo zdravila:
-
Zdravilo, ki se izdaja na veterinarski recept
Status dovoljenja:
-
Valid
Dodatne informacije
Imetnik dovoljenja za promet z zdravilom:
- Zoetis Deutschland GmbH
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
- Zoetis Belgium
Pristojni organ:
- Federal Office Of Consumer Protection And Food Safety
Številka dovoljenja :
- 400790.00.00
Datum spremembe statusa dovoljenja:
Številka postopka:
- BE/V/0029/001
Zadevne države članice:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Kako koristna je bila ta stran?: